Cargando…

Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression

BACKGROUND: Epithelial-mesenchymal transition (EMT) has been known to play a key role in the stromal invasion of carcinoma in situ (CIS) lesion. Loss of E-cadherin and acquisition of vimentin are two critical steps in EMT, that are induced by Snail-1 upregulation associated with overexpression of ep...

Descripción completa

Detalles Bibliográficos
Autor principal:	Myong, Na-Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and The Korean Society for Cytopathology 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479821/ https://www.ncbi.nlm.nih.gov/pubmed/23110026 http://dx.doi.org/10.4132/KoreanJPathol.2012.46.4.341

Ejemplares similares

Significance of E-cadherin and Vimentin as epithelial-mesenchymal transition markers in colorectal carcinoma prognosis
por: Niknami, Zohreh, et al.
Publicado: (2020)

Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
por: Monteiro-Reis, Sara, et al.
Publicado: (2023)

Association of E-cadherin & vimentin expression with clinicopathological parameters in lingual squamous cell carcinomas & their role in incomplete epithelial mesenchymal transition
por: Goyal, Neelakshi, et al.
Publicado: (2021)

Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis
por: Usman, Saima, et al.
Publicado: (2021)

Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix
por: Mayer, A, et al.
Publicado: (2013)

Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis
por: Liu, Xiang, et al.
Publicado: (2014)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

E-cadherin on epithelial–mesenchymal transition in thyroid cancer
por: Zhu, Xiaoyu, et al.
Publicado: (2021)

Evaluating the effect of Alantolactone on the expression of N-cadherin and Vimentin genes effective in epithelial-mesenchymal transition (EMT) in breast cancer cell line (MDA-MB-231)
por: Naderi, Roya, et al.
Publicado: (2022)

The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges
por: Loh, Chin-Yap, et al.
Publicado: (2019)

The association of vimentin and fibronectin gene expression with epithelial-mesenchymal transition and tumor malignancy in colorectal carcinoma
por: Niknami, Zohreh, et al.
Publicado: (2017)

The prognostic marker elastin correlates with epithelial–mesenchymal transition and vimentin‐positive fibroblasts in gastric cancer
por: Fang, Tianyi, et al.
Publicado: (2022)

Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition
por: NILSSON, GISELA M.A., et al.
Publicado: (2014)

Role of N-Cadherin in Epithelial-to-Mesenchymal Transition and Chemosensitivity of Colon Carcinoma Cells
por: Skarkova, Veronika, et al.
Publicado: (2022)

Immunoexpression of N-cadherin, Twist and Vimentin in Bladder Urothelial Carcinomas
por: STEPAN, A.E., et al.
Publicado: (2015)

Long non-coding RNA ZFAS1 is a major regulator of epithelial-mesenchymal transition through miR-200/ZEB1/E-cadherin, vimentin signaling in colon adenocarcinoma
por: O’Brien, Stephen J., et al.
Publicado: (2021)

Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
por: Barillari, Giovanni, et al.
Publicado: (2021)

CANCER OF THE UTERINE CERVIX
Publicado: (1973)

Cancer of the Uterine Cervix
por: Duarte-Franco, Eliane, et al.
Publicado: (2004)

Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions
por: Pinho, Salomé S., et al.
Publicado: (2012)

Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation
por: Liu, Ching-Yi, et al.
Publicado: (2015)

E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition
por: Chen, Augustine, et al.
Publicado: (2014)

Lymphoepithelioma-like carcinoma of the uterine cervix
por: Yun, Hyun Sil, et al.
Publicado: (2017)

N-Cadherin Extracellular Repeat 4 Mediates Epithelial to Mesenchymal Transition and Increased Motility
por: Kim, Jae-Beom, et al.
Publicado: (2000)

Roles of E-cadherin and Noncoding RNAs in the Epithelial–mesenchymal Transition and Progression in Gastric Cancer
por: Bure, Irina V., et al.
Publicado: (2019)

BTBD7 Downregulates E-Cadherin and Promotes Epithelial-Mesenchymal Transition in Lung Cancer
por: Shu, Jie, et al.
Publicado: (2019)

Clinicopathological Significance of Vimentin and Cytokeratin Protein in the Genesis of Squamous Cell Carcinoma of Cervix
por: Husain, Nazik Elmalaika O. S., et al.
Publicado: (2016)

Uterine Cervix Cystic Enlargement
por: Soares, Elisa, et al.
Publicado: (2019)

Uterine Cervix Cystic Enlargement
por: Soares, Elisa, et al.
Publicado: (2019)

Role of epithelial-mesenchymal transition markers E-cadherin, N-cadherin, β-catenin and ZEB2 in laryngeal squamous cell carcinoma
por: Zhu, Guang-Jie, et al.
Publicado: (2018)

VEGF Mediates Tumor Growth and Metastasis by Affecting the Expression of E-Cadherin and N-Cadherin Promoting Epithelial to Mesenchymal Transition in Gastric Cancer
por: Zhang, Yue, et al.
Publicado: (2023)

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
por: Chao, Yvonne L, et al.
Publicado: (2010)

A Positive Role of Cadherin in Wnt/β-Catenin Signalling during Epithelial-Mesenchymal Transition
por: Howard, Sara, et al.
Publicado: (2011)

Cadherin-6B is proteolytically processed during epithelial-to-mesenchymal transitions of the cranial neural crest
por: Schiffmacher, Andrew T., et al.
Publicado: (2014)

Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial–mesenchymal transition-related proteins
por: Liu, Pei-Feng, et al.
Publicado: (2017)

Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression
por: Lobo, João, et al.
Publicado: (2020)

Advanced Maternal Age‐associated SIRT1 Deficiency Compromises Trophoblast Epithelial−Mesenchymal Transition through an Increase in Vimentin Acetylation
por: Xiong, Liling, et al.
Publicado: (2021)

Evaluation of e-cadherin and vimentin expression for different grades of oral epithelial dysplasia and oral squamous cell carcinoma – An immunohistochemical study
por: Puneeta, Nagiredla, et al.
Publicado: (2022)

Loss of breast epithelial marker hCLCA2 promotes epithelial to mesenchymal transition and indicates higher risk of metastasis
por: Walia, Vijay, et al.
Publicado: (2011)

A Case of Adenoid Basal Carcinoma of the Uterine Cervix
por: Kim, Hwi-Gon, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6cjfd4jbncjshapgvd2oqas3km